Air Next

by NuvoAir AB  · Based in Sweden → — Let's build the next generation of cardiopulmonary care.
Allergy & Immunology Pulmonology
Website
Claim this tool
Is this the maker? Claim the company →

Device: $209 usd / 165 eur (excl. vat); platform pricing not publicly available.
Regulatory Status Disclosed

Overview

Air Next by NuvoAir is an advanced, portable spirometer designed for home and clinical use, enabling individuals to measure and monitor their lung function. It connects wirelessly via Bluetooth to the NuvoAir Home smartphone application (iOS and Android), which guides users through spirometry tests and provides real-time insights into their respiratory health. The platform is not a physician directory, but rather a comprehensive digital health solution that leverages collected data, including spirometry measurements (FEV1, FVC, PEF), symptoms, medication usage, and local air quality, to offer personalized insights and facilitate remote monitoring of chronic respiratory conditions. NuvoAir’s broader platform utilizes machine learning algorithms to process this data, providing valuable insights to patients and their healthcare providers to support better clinical decisions and proactive care management. This integrated approach aims to reduce hospitalizations and improve the quality of life for patients with conditions such as asthma, COPD, cystic fibrosis, IPF, ALS, and muscular dystrophy. The NuvoAir Home platform also includes a web-based portal for caregivers and healthcare teams to remotely access and review patient data.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Measures FEV1, FVC, PEF with clinical-grade accuracy
  • Bluetooth wireless connectivity to smartphone/tablet
  • NuvoAir Home mobile app for guided tests and results display
  • Tracks symptoms, medication usage, and local air quality
  • Personalized insights and progress tracking
  • Secure and compliant cloud for data storage and sharing
  • Disposable turbines for hygiene and no calibration needed
  • AI-driven insights from collected spirometry data
  • Care coordination services
  • Web-based portal for healthcare providers

Use Cases

  • Self-management and remote monitoring of chronic respiratory conditions (Asthma, COPD, Cystic Fibrosis, IPF, ALS, Muscular Dystrophy)
  • Decentralized and hybrid clinical trials
  • Supporting healthcare professionals in data-driven clinical decisions
  • Reducing hospitalizations and improving quality of life for patients with COPD
  • Value-based care models
  • Remote patient monitoring programs

What Physicians Need to Know

LIS/LIMS Integration
The NuvoAir platform, which includes Air Next, offers comprehensive reporting and documentation that integrates with Electronic Health Records (EHRs). Patient data collected via the NuvoAir Home app can be automatically shared with connected clinical teams through a Provider Code.
Supported Assay Types
Air Next is a spirometer that measures key lung function parameters including Forced Expiratory Volume in 1 second (FEV1), Forced Vital Capacity (FVC), FEV1/FVC ratio, and Peak Expiratory Flow (PEF). It can also store FEV6, MEF 75, MEF 50, MEF 25, and FEF 25-75.
QC/QA Features
The device utilizes disposable, single-use, pre-calibrated turbines to minimize user error. The accompanying app guides users through the spirometry test and automatically displays the best result from multiple attempts (typically 3-8 tests per session are recommended). Air Next is a CE certified Class IIa Medical Device and has FDA 510(k) clearance, validated against ATS/ISO standard curves. The app also provides 'Session Grading' to assess test performance and reproducibility.
Result Interpretation AI
The NuvoAir app displays results using graphs and animations, and calculates predicted normal values (FEV1, FVC, FEV1/FVC, PEF) based on the user's age, height, race, and gender. It determines obstruction and restriction according to the standard ATS/ERS decision tree. While it provides insights, formal diagnosis and treatment interpretation require a healthcare professional.
Critical Value Alerts
The system is designed to provide high-quality lung data that enables the NuvoAir clinical team to intervene promptly when changes are detected, aiming to provide care before lung function significantly deteriorates.
Instrument Interfaces
The Air Next spirometer connects wirelessly to smartphones and tablets via Bluetooth Low Energy (Bluetooth Smart 4.0 or higher). It is compatible with both iOS and Android devices.
Reference Range Intelligence
The NuvoAir app calculates and displays predicted normal lung function values (FEV1, FVC, FEV1/FVC, PEF) based on ethnicity, gender, age, and height, utilizing reference tables like GLI. Results are presented as a percentage of the predicted value (%pred.).
Turnaround Time Impact
By enabling at-home spirometry, Air Next provides real-time, high-quality, and actionable clinical data, facilitating continuous monitoring and potentially earlier interventions. This can reduce the need for frequent in-person clinic visits and accelerate care plan adjustments. Electronic sharing of results further streamlines communication with healthcare professionals.
Physician Tip

Utilize Air Next for continuous, remote monitoring of lung function in patients with chronic respiratory conditions such as asthma, COPD, and cystic fibrosis. Emphasize proper technique for spirometry tests, as guided by the app, to ensure accurate data. Leverage the app's trend analysis and predicted values to track disease progression and identify potential exacerbations early. Remember that while the device provides valuable data and insights, clinical diagnosis and treatment decisions should always be made by a qualified healthcare professional. Integrate the data into EHRs for a holistic view of patient health and to streamline care coordination.

The NuvoAir platform supports integration with Electronic Health Records (EHRs) for comprehensive reporting and data flow. Data from the Air Next spirometer, via the NuvoAir Home app, can be securely shared with clinical teams using a Provider Code. This facilitates remote patient monitoring and enhances interoperability within the healthcare ecosystem for respiratory care management.

Details

Category Lab & Diagnostics, Telehealth & Virtual Care, Wearables & Remote Monitoring (RPM)
Pricing Device: $209 usd / 165 eur (excl. vat); platform pricing not publicly available. — Device: $209 USD / 165 EUR (excl. VAT); Platform: Contact for pricing
DeploymentMobile app (iOS, Android) and web-based portal
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

The Air Next spirometer received 510(k) clearance (K231416) from the US Food and Drug Administration for in-home use as a full spirometer on January 25, 2024. It is intended to test lung function and spirometry in adults and children 5 years of age and older, for use in hospitals, clinical settings, and at home.
Integrations
EHR Not specified
Specialties Allergy & Immunology, Pulmonology

What the Web Says

The NuvoAir Air Next is an FDA-cleared, smart spirometer designed for both adults and children (5+ years) to measure lung function at home, bridging the gap between clinic and remote care. It's highly regarded by medical professionals for its accuracy, ease of use, and ability to provide real-time, actionable clinical data. The device connects via Bluetooth to a companion app that offers coaching, feedback, and tracks various respiratory parameters, symptoms, and medication usage.

Overall: Positive

Strengths

  • FDA-cleared and ATS/ERS 2019 compliant, ensuring clinical-grade accuracy.
  • Ultra-portable and easy to use, making it suitable for home monitoring.
  • Companion app provides real-time coaching, quality-of-blow feedback, and tracks trends.
  • Utilizes disposable turbines, minimizing maintenance and cleaning.
  • Enables continuous remote patient monitoring, allowing for early intervention and reducing the need for frequent clinic visits.
  • Validated in studies to show good agreement and reproducibility with conventional desktop spirometers.

Limitations

  • Requires continuous purchase of single-use disposable turbines, which can be more expensive long-term.
  • Lacks a built-in display and is entirely dependent on a smartphone or tablet for operation and data display.
  • Performing a full FVC maneuver can be challenging for some patients without in-person coaching.
  • Some users have reported issues with the app crashing or failing to save results, particularly for those with Cystic Fibrosis.
  • Initial Reddit discussions showed some confusion about the overall service offering and its value proposition.

Based on reviews from: MedGrade, Respiratory Therapy, Medical Product Outsourcing, PMC, Apple App Store, FirstWord HealthTech, Healthcare Discovery AI, Reddit

Last updated: 2026-07-18

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Air Next

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

NuvoAir Medical
NuvoAir's Air Next Spirometer is FDA-approved for in-home use
NuvoAir's Air Next Spirometer received formal 510(k) clearance from the FDA for in-home use, allowing full spirometry to be conducted at home for continuous patient monitoring and early intervention for heart and lung conditions.
2024-01
Respiratory Therapy
FDA Clears NuvoAir's Air Next Spirometer for Home Use
The FDA granted 510(k) clearance to NuvoAir's Air Next spirometer for in-home use, enabling continuous monitoring and timely intervention for patients with conditions like COPD and asthma.
2024-02
Medical Device Network
FDA approves NuvoAir's home-use spirometer
The US FDA has granted 510(k) clearance to NuvoAir for the in-home use of its Air Next spirometer, allowing individuals to perform comprehensive lung function tests at home for conditions such as COPD, asthma, and ALS.
2024-01
NuvoAir Medical
NuvoAir's Air Next Spirometer is Now EU MDR Certified
NuvoAir's Air Next spirometer received an updated CE mark certification, complying with the new European Medical Device Regulation (EU MDR) for enhanced safety and efficacy of medical devices.
2023-12
PMC (Respiratory Research)
Validation of the portable Bluetoothu00ae Air Next spirometer in patients with different respiratory diseases
This study validates the Air Next spirometer as a reliable device for screening and diagnosing various spirometric patterns in clinical practice, connecting via Bluetooth to a smartphone or tablet for measurements.
2020-04
ERS Publications (European Respiratory Journal)
Validation study of the quality of home spirometry performed by Air Next spirometer in combination with mobile coaching system: preliminary results
Preliminary results from this study support the unsupervised home use of the Air Next spirometer with a mobile coaching system for reliable, high-quality lung function measurements and remote monitoring of asthma patients.
2020-09
Cystic Fibrosis News Today
NuvoAir Home Platform Classified as Class Im Medical Device
The NuvoAir Home platform, which includes the Air Next spirometer, has been classified as a Class Im Medical Device under the European Medical Device Directive, indicating it meets safety and performance requirements for medical devices in the European Economic Area.
2020-08
Business Wire
NuvoAir Launches Air Next, Revolutionary New Home Device to Help Those with Serious Lung Conditions
NuvoAir launched the Air Next, a new hand-held, Bluetooth-enabled home spirometer designed to help individuals with ongoing lung conditions like asthma, COPD, and cystic fibrosis self-manage their health.
2018-04

Videos

Product demos, reviews, and walkthroughs for Air Next.

View all on YouTube

Frequently Asked Questions

The Air Next spirometer connects to smartphones via Bluetooth, enabling patients to perform lung function measurements at home and transmit results electronically to healthcare professionals. NuvoAir's platform, which incorporates Air Next, aims to integrate this high-quality lung data into continuous patient care, though specific EHR integration details would require direct inquiry with NuvoAir.
Air Next is designed for detecting, assessing, and monitoring diseases affecting lung function, such as asthma, COPD, and cystic fibrosis, in patients over 5 years old. It measures Forced Expiratory Volume in 1 second (FEV1) and Forced Vital Capacity (FVC), parameters consistent with those recorded by medical professionals, and has received FDA 510(k) clearance for in-home use as a full spirometer.
The Air Next spirometer is a Class IIa medical device that holds a CE mark and has received FDA 510(k) clearance for in-home use, demonstrating its adherence to medical device regulatory standards. NuvoAir Medical emphasizes maintaining data safety and deliberate AI use, which typically includes compliance with data privacy regulations like HIPAA.
While Air Next provides real spirometry technology for home monitoring, its home use is primarily for indicative purposes, and a definitive diagnosis must be made by a physician. The device is intended for use by healthcare professionals or individuals trained in performing spirometry, with the accompanying app offering guidance and allowing for symptom notation.
The Air Next spirometer is positioned as an affordable device for personal use, costing approximately $209 USD or 165 EUR (excluding VAT) at its launch. This pricing is significantly lower than most standard spirometers found in clinical settings, aiming to enhance accessibility for patients requiring home lung function monitoring.
While the search results did not explicitly detail direct competitors for the NuvoAir Air Next spirometer in remote lung function monitoring, the broader digital health market offers various AI solutions for patient monitoring and care. Physicians might consider other remote patient monitoring platforms or specialized respiratory digital health tools depending on specific patient needs and clinical objectives.
NuvoAir designs the Air Next spirometer and its intuitive Smart One app for ease of use by both healthcare professionals and trained individuals. The company aims to empower patients in managing their health and improve communication with their doctors, suggesting that support and training resources are available for effective system utilization.

Related Tools

LabLynx AI-Powered LIMS
LabLynx
Lab & Diagnostics
LabLynx AI-Powered LIMS integrates AI and Machine Learning into laboratory information management systems to automate complex analyses, predict outcomes, and optimize workflows for various lab settings. The platform offers LIMS, ELN, and Lab Automation suites, providing configurable and scalable solutions for diverse laboratory needs.
August AI
August AI
Lab & Diagnostics
August AI offers an AI-enabled telehealth platform with an AI health chatbot and virtual care services, including telehealth visits and prescription management. The company's AI chatbot is available globally for free, providing information and not medical advice. In the U.S., August AI offers August Care, a membership that provides clinical services, discounted labs, and quick prescriptions.
$0 (chatbot) / $39 per visit / $39 per month (august care membership)
Allergios®
Allergios®
Lab & Diagnostics
Allergios® is developing an in-vitro diagnostic system that directly visualizes allergic responses in blood serum to provide unambiguous allergy diagnoses, starting with food allergies.
PNOĒ
PNOĒ
Endocrinology & Metabolic AI
PNOĒ is a science-backed cardiometabolic analyzer that performs comprehensive breath-based assessments to measure 23 biomarkers, including VO₂ max, resting metabolic rate (RMR), fat burn efficiency, and biological age. It delivers a 360° snapshot of an individual's physiology by analyzing how oxygen flows through the lungs, heart, and cells. The insights generated are used to personalize nutrition, exercise, and longevity plans.
Varies
Folklore Clinical Variant Interpretation
Helena Bioinformatics
Lab & Diagnostics
Folklore is a clinical variant interpretation platform for genetic laboratories and researchers that brings genomic annotation, ACMG/AMP classification, phenotype and inheritance evidence, literature, and structured reporting into one traceable workflow.
Freemium
Insitro
Insitro
Drug Discovery & Research
Insitro combines automated cellular experiments with population-scale genetics to build Physical AI systems that reveal causal drivers of human disease and deliver targeted therapeutics.

See all Lab & Diagnostics tools →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18

Investors who backed Air Next

Funded through the company that built this tool.

Industrifonden
VC T3
Stockholm, Sweden
$1M-$5M
Industrifonden is a Stockholm-based evergreen venture fund, originally established as a Swedish state-backed investor and now operating independently with permanent capital, investing…
Biotech Diagnostics
AI Tool Finder
AI-powered search. Results may not be comprehensive.